Adam Taylor

Phosphonocarboxylates Inhibit the Second Geranylgeranyl Addition by Rab Geranylgeranyl Transferase*

R. Baron, R. Tavaré, M. Rogers, 2009, Journal of Biological Chemistry.

Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial.

P. McGuire, P. Morrison, W. Cubała, 2017, The American journal of psychiatry.

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis.

A. Hart, S. Bloom, J. Lindsay, 2018, Inflammatory bowel diseases.

An observational postmarketing safety registry of patients in the UK, Germany, and Switzerland who have been prescribed Sativex® (THC:CBD, nabiximols) oromucosal spray

S. Wright, H. Lauder, Adam Taylor, 2016, Therapeutics and clinical risk management.

Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial

Eric Marsh, Dennis Dlugos, Venkatesh Nagaraddi, 2018, The Lancet.